Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | -6.41% | +8.01% | +20.67% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Lawler
FOU | Founder | 52 | 20-04-22 |
Chief Executive Officer | 54 | 23-10-04 | |
Daniel George
DFI | Director of Finance/CFO | 54 | 23-09-27 |
Kenneth Cundy
CTO | Chief Tech/Sci/R&D Officer | 65 | 22-05-19 |
Madison Damour
IRC | Investor Relations Contact | - | - |
Scott Anderson
IRC | Investor Relations Contact | - | 22-01-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jason Aryeh
BRD | Director/Board Member | 56 | 21-02-28 |
Kenneth Lin
BRD | Director/Board Member | 51 | 21-01-31 |
Bimal Shah
BRD | Director/Board Member | 48 | 23-10-04 |
Chief Executive Officer | 54 | 23-10-04 | |
Director/Board Member | 42 | 22-10-31 | |
Karah Parschauer
BRD | Director/Board Member | 46 | 21-01-31 |
Joseph Lawler
FOU | Founder | 52 | 20-04-22 |
Aron English
BRD | Director/Board Member | 41 | 20-05-31 |
Areta Kupchyk
BRD | Director/Board Member | 67 | 21-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,933,217 | 8,978,689 ( 34.62 %) | 0 | 34.62 % |
Company contact information
Anebulo Pharmaceuticals, Inc.
1017 Ranch Road 620 South Suite 107
78734, Lakeway
+(512) 598-0931
http://www.anebulo.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.67% | 80.91M | |
+24.02% | 48.09B | |
+46.90% | 40.62B | |
-2.47% | 40.43B | |
-6.95% | 28.36B | |
+7.47% | 24.89B | |
-19.92% | 19.01B | |
+28.86% | 12.09B | |
-0.56% | 11.88B | |
-0.50% | 11.8B |
- Stock Market
- Equities
- ANEB Stock
- Company Anebulo Pharmaceuticals, Inc.